Nicole Riley
Head of Investor Relations and Corporate Communications
Replay available
ADC Therapeutics SA (ADCT) Q3 2025 Earnings Call
ADC Therapeutics SA (NYSE: ADCT) Q3 2025 earnings conference call, held 2025-11-10. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Amit Malik
Chief Executive Officer
Mohamed Zaki
Chief Medical Officer
Pepe Carmona
Chief Financial Officer
Eric Schmidt
Analyst, Cantor
Jenna Lee
Analyst, Jefferies
Michael Schmidt
Analyst, Guggenheim Securities
Leonid Kimashev
Analyst, RBC Capital Markets
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Adc Therapeutics Sa.
Replay transcript excerpt
WEBVTT 00:00:01.094 -- 00:00:06.801 Good morning, ladies and gentlemen, and welcome to the ADC Therapeutics Q3 2025 00:00:06.801 -- 00:00:11.527 Earnings Conference Call. At this time, all lines are in listen-only mode. 00:00:11.527 -- 00:00:15.491 Following the presentation, we will conduct a question-and-answer session. 00:00:15.491 -- 00:00:19.696 If at any time during this call you require immediate assistance, please press star zero 00:00:19.696 -- 00:00:25.003 for the operator. This call is being recorded on Monday, November 10, 2025. 00:00:25.003 -- 00:00:29.575 I will now turn the call over to Nicole Riley, Head of Head of Investor Relations and 00:00:29.575 -- 00:00:32.780 Corporate Communications for ADC Therapeutics. 00:00:32.780 -- 00:00:35.721 Nicole, please go ahead. 00:00:36.725 -- 00:00:41.813 Thank you, Operator. Today, we issued a press release announcing our third quarter 2025 00:00:41.813 -- 00:00:46.840 financial results and business updates. This release and the slides we will use 00:00:46.840 -- 00:00:51.767 in today's presentation are available on the Investors section of the ADC Therapeutics 00:00:51.767 -- 00:00:53.369 website. 00:00:53.369 -- 00:00:58.743 I'm joined on today's call by our Chief Executive Officer, Amit Malik, who will discuss 00:00:58.743 -- 00:01:02.287 our operational performance and recent business highlights. 00:01:02.287 -- 00:01:07.934 Our Chief Medical Officer, Mohamed Zaki, who will discuss our clinical programs and updates, 00:01:07.934 -- 00:01:13.241 followed by our Chief Financial Officer, Pepe Carmona, who will review our third quarter 00:01:13.241 -- 00:01:19.186 2025 financial results. We will then open the call to questions. 00:01:19.408 -- 00:01:23.734 Before we begin, I would like to remind listeners that s...